Health
RPT-Lonza confident of 2020 target for Moderna COVID-19 vaccine supply – Reuters
Lonza is confident that U.S. and Swiss plants it is building to help make Moderna’s COVID-19 vaccine candidate will be ready for commercial production this year…
(Repeating to add TV in slug)
* Lonza confident on 2020 target for Moderna vaccine
* Swiss locals watching, hoping for project success
* Swiss company focusing on drugs, selling chemicals unit
VISP, Switzerland, Sept 29 (Reuters) – Lonza is confident that U.S. and Swiss plants it is building to help make Modernas COVID-19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.
New production lines at Lonzas site in Portsmouth, Ne…
-
General12 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Noosa News21 hours agoJane Edmanson hangs up her Gardening Australia hat, reflects on labour of love behind show’s success
-
Business16 hours agoWhy this ASX 200 tech stock could rise 20%
-
Business18 hours ago3 of the best ASX ETFs for beginners to buy with $1,000